Johnson & Johnson
JNJ
#25
Rank
A$587.51 B
Marketcap
$244.02
Share price
0.17%
Change (1 day)
4.40%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Revenue for Johnson & Johnson (JNJ)

Revenue in 2024 (TTM): A$130.23 Billion

According to Johnson & Johnson's latest financial reports the company's current revenue (TTM ) is A$133.63 Billion. In 2023 the company made a revenue of A$124.99 Billion a decrease over the revenue in the year 2022 that were of A$133.94 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Johnson & Johnson from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) A$130.23 B4.19%
2023 A$124.99 B-6.68%
2022 A$133.94 B3.55%
2021 A$129.34 B20.43%
2020 A$107.40 B-8.36%
2019 A$117.20 B1.21%
2018 A$115.80 B18.26%
2017 A$97.92 B-1.81%
2016 A$99.73 B3.68%
2015 A$96.19 B5.91%
2014 A$90.82 B13.61%
2013 A$79.94 B23.59%
2012 A$64.68 B2%
2011 A$63.42 B4.6%
2010 A$60.63 B-12.01%
2009 A$68.90 B-23.74%
2008 A$90.35 B29.3%
2007 A$69.88 B3.31%
2006 A$67.64 B-2.02%
2005 A$69.03 B12.83%
2004 A$61.18 B8.64%
2003 A$56.31 B-12.58%
2002 A$64.42 B1.19%
2001 A$63.67 B20.53%
2000 A$52.82 B24.76%
1999 A$42.34 B9.59%
1998 A$38.63 B11.24%
1997 A$34.73 B27.62%
1996 A$27.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
A$84.79 B-36.55%๐Ÿ‡บ๐Ÿ‡ธ USA
A$95.21 B-28.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$74.45 B-44.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$77.92 B-41.69%๐Ÿ‡ซ๐Ÿ‡ท France
A$32.59 B-75.61%๐Ÿ‡บ๐Ÿ‡ธ USA
A$49.64 B-62.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$59.31 B-55.62%๐Ÿ‡บ๐Ÿ‡ธ USA
A$62.06 B-53.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$60.14 B-55.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$42.36 B-68.30%๐Ÿ‡บ๐Ÿ‡ธ USA